X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
75
PharmaCompass offers a list of Ketorolac Trometamol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ketorolac Trometamol manufacturer or Ketorolac Trometamol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ketorolac Trometamol manufacturer or Ketorolac Trometamol supplier.
PharmaCompass also assists you with knowing the Ketorolac Trometamol API Price utilized in the formulation of products. Ketorolac Trometamol API Price is not always fixed or binding as the Ketorolac Trometamol Price is obtained through a variety of data sources. The Ketorolac Trometamol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ketorolac Tromethamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ketorolac Tromethamine, including repackagers and relabelers. The FDA regulates Ketorolac Tromethamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ketorolac Tromethamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ketorolac Tromethamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ketorolac Tromethamine supplier is an individual or a company that provides Ketorolac Tromethamine active pharmaceutical ingredient (API) or Ketorolac Tromethamine finished formulations upon request. The Ketorolac Tromethamine suppliers may include Ketorolac Tromethamine API manufacturers, exporters, distributors and traders.
click here to find a list of Ketorolac Tromethamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ketorolac Tromethamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Ketorolac Tromethamine active pharmaceutical ingredient (API) in detail. Different forms of Ketorolac Tromethamine DMFs exist exist since differing nations have different regulations, such as Ketorolac Tromethamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ketorolac Tromethamine DMF submitted to regulatory agencies in the US is known as a USDMF. Ketorolac Tromethamine USDMF includes data on Ketorolac Tromethamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ketorolac Tromethamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ketorolac Tromethamine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ketorolac Tromethamine Drug Master File in Korea (Ketorolac Tromethamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ketorolac Tromethamine. The MFDS reviews the Ketorolac Tromethamine KDMF as part of the drug registration process and uses the information provided in the Ketorolac Tromethamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ketorolac Tromethamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ketorolac Tromethamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ketorolac Tromethamine suppliers with KDMF on PharmaCompass.
A Ketorolac Tromethamine CEP of the European Pharmacopoeia monograph is often referred to as a Ketorolac Tromethamine Certificate of Suitability (COS). The purpose of a Ketorolac Tromethamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ketorolac Tromethamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ketorolac Tromethamine to their clients by showing that a Ketorolac Tromethamine CEP has been issued for it. The manufacturer submits a Ketorolac Tromethamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ketorolac Tromethamine CEP holder for the record. Additionally, the data presented in the Ketorolac Tromethamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ketorolac Tromethamine DMF.
A Ketorolac Tromethamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ketorolac Tromethamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ketorolac Tromethamine suppliers with CEP (COS) on PharmaCompass.
A Ketorolac Tromethamine written confirmation (Ketorolac Tromethamine WC) is an official document issued by a regulatory agency to a Ketorolac Tromethamine manufacturer, verifying that the manufacturing facility of a Ketorolac Tromethamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ketorolac Tromethamine APIs or Ketorolac Tromethamine finished pharmaceutical products to another nation, regulatory agencies frequently require a Ketorolac Tromethamine WC (written confirmation) as part of the regulatory process.
click here to find a list of Ketorolac Tromethamine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ketorolac Tromethamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ketorolac Tromethamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ketorolac Tromethamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ketorolac Tromethamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ketorolac Tromethamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ketorolac Tromethamine suppliers with NDC on PharmaCompass.
Ketorolac Tromethamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ketorolac Tromethamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ketorolac Tromethamine GMP manufacturer or Ketorolac Tromethamine GMP API supplier for your needs.
A Ketorolac Tromethamine CoA (Certificate of Analysis) is a formal document that attests to Ketorolac Tromethamine's compliance with Ketorolac Tromethamine specifications and serves as a tool for batch-level quality control.
Ketorolac Tromethamine CoA mostly includes findings from lab analyses of a specific batch. For each Ketorolac Tromethamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ketorolac Tromethamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ketorolac Tromethamine EP), Ketorolac Tromethamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ketorolac Tromethamine USP).
Market Place
